GoodRx is a great small-cap value stock to buy amid the recent downturn. I'm upgrading the stock to a buy. GoodRx showcases strong adjusted EBITDA despite slower growth, making it an attractive target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback